Skip to content
Contact Us
Technology
Clinical Program
Discovery Platform
Pipeline
About Us
News
Menu
Technology
Clinical Program
Discovery Platform
Pipeline
About Us
News
Technology
Clinical Program
Discovery Platform
Pipeline
About Us
News
Contact Us
Menu
Technology
Clinical Program
Discovery Platform
Pipeline
About Us
News
Contact Us
Back
Events
MBrace Therapeutics Presents Preclinical Data Demonstrating Potential of Novel Antibody Drug Conjugate at AACR 2024
April 7, 2024
More news
Read the
Events
→
MBrace Therapeutics Appoints Steve Alley as Chief Scientific Officer
Read the
Events
→
MBrace Therapeutics Presents Trial in Progress Poster for Lead Antibody-Drug Conjugate Program at 2024 ASCO Annual Meeting
More news
Read the
Events
→
MBrace Therapeutics Appoints Steve Alley as Chief Scientific Officer
Read the
Events
→
MBrace Therapeutics Presents Trial in Progress Poster for Lead Antibody-Drug Conjugate Program at 2024 ASCO Annual Meeting
For more information about MBrace’s products or programs please contact us at:
info@mbracetrx.com
